Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients

International Journal of Artificial Organs

Volumn 26, Issue 11, 2003, Pages 1039-1043

  Kurtoglu, Erdal ^a   Ugur, A ^a   Sait Gonen, M ^a   Kisakol, G ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Familial hypercholesterolemia; Lipid apheresis; Oxidative stress

Indexed keywords

ENZYMES; LIPOPROTEINS; OXIDATIVE STRESS;

ANTIOXIDANT STATUS; EFFECTIVE THERAPY; FAMILIAL HYPERCHOLESTEROLEMIA; GLUTATHIONE PEROXIDASE; LIPID APHERESIS; LOW DENSITY LIPOPROTEINS; SUPER OXIDE DISMUTASE; SUPEROXIDE DISMUTASES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOBARBITURIC ACID-REACTIVE SUBSTANCES;

ANTIOXIDANTS;

CATALASE; GLUTATHIONE PEROXIDASE; LIPID; LIPOPROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; APHERESIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; EXTRACORPOREAL CIRCULATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; OXIDATIVE STRESS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 1242297089     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302601110     Document Type: Article

References (18)

1. Yamamoto A, Harada-Shiba M, Kawaguchi A, Tsushima M. Apheresis technology for prevention and regression of atherosclerosis. Ther Apher 2001; 5: 221-5.
2. Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher 2001; 5: 244-51.
3. Blaha M. Extracorporeal LDL-cholesterol in the treatment severe familial hypercholesterolemia. Acta Med 2003; 46: 3-7.
4. Thompson GR. LDL apheresis. Atherosclerosis 2003; 167: 1-13.
5. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic atatus on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163-76.
6. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2533-6.
7. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 1973; 247: 3170-5.
8. Aebi HE. Catalase of enzymatic analysis. In: Bergmeyer HU, ed. Volume III enzymes 1. Oxidoreductases, transferases. Weinheim: VCH Verlagsgesellschaft, 1987; 273-85.
9. Baricchi R, Pizzala R, Cacciavillani G, Rivasi P, Tomasi A. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients. Ther Apher 1998; 2: 218-23.
10. Klingel R, Fassbender T, Fassbender C, Gohlen B. From membrane differential filtration to lipid filtration: Tecnological progress in low-density lipoprotein apheresis. Therap Apher Dial 2003; 7: 350-8.
11. Bambauer R. Low-density lipoprotein apheresis: Clinical results with different methods. Artif Organs 2002; 26: 133-9.
12. Kobayashi J, Katsube S, Shimoda M, Furuhashi K, Kitano S, at al. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde modify low-density lipoprotein concentration in Japanese hypercholesterolemic subjects. Clin Chim Acts, 2002; 321: 107-12.
13. Fadul JE, Vessby B, Wikstrom B, Danielson BG. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: A 4 year follow-up study. Artif Organs 1997; 21: 364-8.
14. Stefanutti C, Di Giacomo S, Vivenzio A, Isacchi GC, Masella R, et al. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolamia. Clin Sci 2001; 100: 191-8.
15. Hulhte J, Wikstrand J, Lidell A, Wendelhag I, Hansson GK, et al. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998; 18: 1203-11.
16. Hussein O, Frydman O, Frim H, Aviram M. Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children. Pathophysiology 2001; 8, 21-8.
17. Lubrano V, Vassalle C, Blandizzi C, Del Tacca M, Palombo C, et al. The effect of lipoprotein on endothelial nitric oxide synthase modulated by lipoperoxides. Eur J Clin Invest 2003; 33: 117-25.
18. Delattre J, Lepage S, Jaudon MC, Bruckert E, Assogba U, et al. The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis. Ann Pharm Fr 1998; 56: 18-25.